Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
Open accessPublished version of a preprint
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Large-scale molecular profiling and genotyping provide a unique opportunity to systematically compare the genetically predicted effects of therapeutic targets on the human metabolome. We firstly constructed genetic risk scores for 8 drug targets on the basis that they primarily modify low-density lipoprotein (LDL) cholesterol (HMGCR, PCKS9, and NPC1L1 ) , high-density lipoprotein (HDL) cholesterol (CETP), or triglycerides (APOC3, ANGPTL3, ANGPTL4, and LPL). Conducting mendelian randomisation (MR) provided strong evidence of an effect of drug-based genetic scores on coronary artery disease (CAD) risk with the exception of ANGPTL3. We then systematically estimated the effects of each score on 249 metabolic traits derived using blood samples from an unprecedented sample size of up to 115,082 UK Biobank participants. Genetically predicted effects were generally consistent among drug targets, which were intended to modify the same lipoprotein lipid trait. For example, the linear fit for the MR estimates on all 249 metabolic traits for genetically predicted inhibition of LDL cholesterol lowering targets HMGCR and PCSK9 was r 2 = 0.91. In contrast, comparisons between drug classes that were designed to modify discrete lipoprotein traits typically had very different effects on metabolic signatures (for instance, HMGCR versus each of the 4 triglyceride targets all had r 2 < 0.02). Furthermore, we highlight this discrepancy for specific metabolic traits, for example, finding that LDL cholesterol lowering therapies typically had a weak effect on glycoprotein acetyls, a marker of inflammation, whereas triglyceride modifying therapies assessed provided evidence of a strong effect on lowering levels of this inflammatory biomarker. Our findings indicate that genetically predicted perturbations of these drug targets on the blood metabolome can drastically differ, despite largely consistent effects on risk of CAD, with potential implications for biomarkers in clinical development and measuring treatment response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Genetically proxied levels of lipids were significantly associated with CAD33,34”
From Genetic insights into causal effects of lipids and lipid-modifying targets on calcific aortic valve stenosis: a Mendelian randomized study (2025) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ggplot2: Elegant Graphics for Data Analysis
Ginestet, C. (2011) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2010.00676_9.x · Cited by 13,726 · cited 1×
“All plots in this study were generated using the R package “ggplot2” [52].”
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728 · cited 1×
“Genetic instruments for each lipid-modifying drug target were selected by undertaking GWAS of lipoprotein lipid traits measured using a conventional biochemistry assay in UKB [44].”
The UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711 · cited 1×
“We conducted linkage disequilibrium (LD) pruning for variants such that they had r 2 0.1 using a reference panel of 503 European individuals enrolled in the 1,000 Genomes Project phase 3 (version 5) [47].”
InfluentialMendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050 · cited 2×
“Two-sample MR analyses were undertaken using the inverse variance weighted (IVW) method while accounting for the correlation between instruments [22,23] ( Fig 1 ).”
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962
A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
the CARDIoGRAMplusC4D Consortium (2015) · Nature Genetics · doi:10.1038/ng.3396 · Cited by 2,447
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857 · cited 1×
“Circulating lipoprotein lipid concentrations are of central importance to the aetiology of CAD [2,3].”
Mahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744 · cited 1×
“Genetic estimates on T2D were extracted from a previous GWAS from the DIAMANTE consortium consisting of 74,124 cases and 824,006 controls of European ancestry [50].”
Research works printed but not linked: 1
- Mendes PFAPP Moura JMSP, 2020, New drugs coming up in the field of lipid control, e-Journal of Cardiology. Practice, 19
Cited by
Items 101–200 of 304
Ponomarenko, M., Reshetnikov, E., Churnosova, M., Aristova, I., Abramova, M. Y., Борисович, Н. В., Churnosov, V., Polonikov, A., Churnosov, M. I., & Ponomarenko, I. (2025) · Life · doi:10.3390/life15091459 · Cited by 7
The genetics of falling susceptibility and identification of causal risk factors
Smith, M. C., O’Loughlin, J., Karageorgiou, V., Casanova, F., Williams, G., Hilton, M. P., & Tyrrell, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-44566-w · Cited by 7
“This variant has been identified in many GWAS studies including plasma levels 34 , LDL-cholesterol 35 , superior frontal cortical thickness 36 , Alzheimer’s disease 37 and longevity 38 .”
BackgroundAdaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis
Misicka, E., Huang, Y., Loomis, S. J., Sadhu, N., Fisher, E., Gafson, A., Runz, H., Tsai, E. A., Jia, X., Herman, A. H., et al. (2024) · Neurology Genetics · doi:10.1212/nxg.0000000000200159 · Cited by 6
Tao, H.-W., Liu, Z., Jiang, W., Miao, M.-Y., Lyu, J., Zhao, M., Zhu, J., Chen, J., Du, H., Li, Z., et al. (2024) · Food & Function · doi:10.1039/d4fo00987h · Cited by 6
Systematic Mendelian Randomization Exploring Druggable Genes for Hemorrhagic Strokes
Yang, L.-Z., Yang, Y., Hong, C., Wu, Q., Shi, X., Liu, Y.-L., & Chen, G. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04336-9 · Cited by 6
The association between metabolic syndrome and lung cancer risk: a Mendelian randomization study
Wei, Z., Hu, Y., Zuo, F., Wen, X., Wu, D., Sun, X., & Liu, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-79260-y · Cited by 6
“For TG and HDL-C, summary-level statistics were extracted from the UK Biobank with 441,016 and 115,082 participants 22,23 .”
Zou, C., Yang, B., Zhang, J., Zhang, Y., Ye, D., Zhu, H., Bai, T., & Jiang, G. (2025) · Phenomics · doi:10.1007/s43657-024-00212-7 · Cited by 5
“The MR-Egger intercept detected the significant pleiotropy in the causal links of HDL-C levels with S13), indicating the effectiveness of the genetic instruments, except for ANGPTL3, which was consistent with previous studies (Richardson et al. 2022; Wang et al. 2021).”
Wang, B., Yang, Y., Yin, Z., & Yang, W. (2025) · Scientific Reports · doi:10.1038/s41598-024-84165-x · Cited by 6
Henry, D., Baugé, E., Staels, B., & Lalloyer, F. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100086 · Cited by 5
Chen, W., Chen, M., Huang, J., Xie, Q., Huang, Y., Chen, C., & Zhu, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1408647 · Cited by 5
Qiu, Y., Song, B., Yin, Z., Wang, M., Tao, Y., Xie, M., Duan, A., Chen, Z., Si, K., & Wang, Z. (2024) · European Stroke Journal · doi:10.1177/23969873241265019 · Cited by 5
“The outcomes of sensitivity analyses are presented in Supplemental Tables 16–18.”
Zhou, T., Lin, W., Yang, B., Liu, Y., Huang, W., Xie, N., Yang, F., Lin, Z., Hu, Z., Luo, S., et al. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02466-0 · Cited by 7
He, M., Zhang, H., Luo, Z., Duan, X., Zhao, F., Su, P., Zeng, Z., Zhou, L., Chen, C., & Qiu, J. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.02.099 · Cited by 6
Wąsowska, A., Sendecki, A., Boguszewska‐Chachulska, A. M., & Teper, S. J. (2023) · Genes · doi:10.3390/genes14091707 · Cited by 5
“The second variant in our model, rs148662546, has been associated with the ratio of omega-3 fatty acids to total fatty acids in GWASs [34].”
BackgroundInfluentialZou, J., Qi, S., Sun, X., Zhang, Y., Wang, Y., Li, Y., Zhao, Z., & Lei, D. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.116909 · Cited by 5
One-carbon metabolism and risk of PCOS: insights from Mendelian randomization
Zhao, Y., Zhang, G., Pan, J., & Huang, H. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01795-z · Cited by 5
“Genetic instruments of branched-chain amino acids (BCAAs), adjusted for age, BMI, and obesity at assessment were accessed from 115 047 participants [50].”
UK Biobank: Transforming drug discovery and precision medicine
Bešević, J., Said, S., Nagy, R., Jamshidi, Y., Whelan, C. D., Carson, L., Rutter, M. K., Lewandowski, A. J., Effingham, M., Collins, R., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70254 · Cited by 4
“For example, genetically predicted inhibition of LDL-cholesterol lowering targets, HMGCR and PCSK9, is associated with (expected) lower lipoprotein levels but had a negligible effect on glycoprotein acetyls levels, an NMR-derived bio-marker of systemic inflammation (Richardson et al., 2022).”
Miao, S., Wang, X., Ma, L., & You, C. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308301 · Cited by 4
Li, K., Leng, Y., Lei, D., Zhang, H., Ding, M., & Lo, W. L. A. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1424286 · Cited by 4
The metabolic signature of blood lipids: a causal inference study using twins
Wang, Y., Liu, S., Cao, W., Lv, J., Yu, C., Huang, T., Sun, D., Liao, C., Pang, Y., Pang, Z., et al. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100625 · Cited by 4
Yang, Y., Wang, X., & Yang, W. (2024) · Journal of Dairy Science · doi:10.3168/jds.2024-25585 · Cited by 5
Zhou, J., Jiang, S., Liu, D., Li, X., Zhou, Z., Wang, Z., & Wang, H. Z. (2024) · Nutrients · doi:10.3390/nu16213748 · Cited by 4
“…Catalog [30] on 19 February 2024 to examine the association between genetic variants and plasma levels of fa tt y acids [29]. statistics downloaded from the NHGRI-EBI GWAS Catalog [30] on 19 February 2024 to examine the association between genetic variants and plasma levels of fatty acids [29].”
MethodInfluentialFatty acid traits mediate the effects of uric acid on cancers: a Mendelian randomization study
Li, J., Zhang, Y., Fu, T., Wang, S., Cai, H., Xu, F., Xing, G., & Tong, Y. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1449205 · Cited by 5
Li, M., Duan, H., Luo, J., Tan, Y. T., Liu, M., Zhao, X., Shi, D., & Ma, X. (2024) · Medicine · doi:10.1097/md.0000000000040770 · Cited by 4
Zhao, F., Yang, Y., & Yang, W. (2025) · Scientific Reports · doi:10.1038/s41598-024-83217-6 · Cited by 6
Zhang, H., Zhou, Z., Gu, J., Lin, Y., Yan, Y., Chen, X., Fan, M., & Huang, Y. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111282 · Cited by 4
Sagulkoo, P., Chuntakaruk, H., Suratanee, A., Plaimas, K., & Teerakulkittipong, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-07989-1 · Cited by 5
Maushagen, J., Nattenmüller, J., von Krüchten, R., Thorand, B., Peters, A., Rathmann, W., Adamski, J., Schlett, C. L., Bamberg, F., Wang‐Sattler, R., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01309-z · Cited by 4
Wuni, R., Amerah, H., Ammache, S., Cruvinel, N. T., da Silva, N. R., Kuhnle, G., Horst, M. A., & Vimaleswaran, K. S. (2024) · British Journal Of Nutrition · doi:10.1017/s0007114524001594 · Cited by 4
Education and metabolic syndrome: a Mendelian randomization study
Liu, D., Xu, Z., Liu, X., Yang, H.-L., Wang, L., & Li, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1477537 · Cited by 5
Fu, L., Liu, Q., Cheng, H., Zhao, X., Xiong, J., & Mi, J. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038857 · Cited by 6
Genotype‐driven NPC1L1 and PCSK9 inhibition and reduced risk of periodontitis
Baumeister, S., Holtfreter, B., Reckelkamm, S. L., Kocher, T., Alayash, Z., Ehmke, B., Baurecht, H., & Nolde, M. (2022) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13719 · Cited by 4
LAVAA: a lightweight association viewer across ailments
Fauman, E. B., Keppo, S., Cerioli, N., Vyas, R., Kurki, M., Daly, M. J., & Reeve, M. P. (2023) · Bioinformatics Advances · doi:10.1093/bioadv/vbad018 · Cited by 4
Wu, C., Pu, Q., Zou, Y., Jin, J., Lei, Y., Hu, Y., Chen, Z., & Yu, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-15525-4 · Cited by 3
“The positive control analyses identified associations in the expected direction between genetically proxied drug targets and CAD, ensuring the validity of the genetic instruments (Supplementary table S7).”
Fang, J. X., Zou, H.-M., Meng, J., Yu, H., Hu, X., Gu, Q., Wang, S. J., & Liu, X. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100662 · Cited by 4
Chen, S., He, G., Zhang, M., Tang, N., & Zeng, Y. (2024) · Hematology · doi:10.1080/16078454.2024.2433904 · Cited by 3
“…this study were total serum BCAA levels (leucine + isoleucine + valine) (ebi-a-GCST90092984), leucine levels (ebi-a-GCST90092891), isoleucine levels (ebi-a-GCST90092843), and valine levels (ebi-a-GCST90092995), derived from a genome-wide association study (GWAS) dataset of the same population [14].”
Xie, Y., Bai, R., Ren, L., Fan, H., Tuo, H., Duan, L., Zhou, X., Fang, C., Li, Z., & Zheng, Y. (2025) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70176 · Cited by 3
“…Kettunen et al.'s 2016 study, which quantified 123 blood metabolite traits in up to 24 925 individuals [20], and Richardson et al.'s 2022 study, which systematically estimated the effects of genetic variants on 249 metabolic traits in blood samples from up to 115 082 UK Biobank participants [21].”
Polyunsaturated Fatty Acids and Skin Cancer: Two-Sample Mendelian Randomization Study
Kim, G., Kim, B. R., Paik, K., Jin, S., Park, H., Myung, W., Lee, J., Choi, C. W., & Kim, J.-H. (2025) · Annals of Dermatology · doi:10.5021/ad.25.095 · Cited by 3
“To facilitate cross-trait comparisons and minimize the influence of outliers, all PUFA measurements were standardized using inverse-rank normalization 14 .”
Roozbehi, K., Semirani-Nezhad, D., Alipour, B., Javadian, P., Sadeghi, M., Mashayekh, M., Javdani, F., Attar, A., Hosseinpour, A., Askari, M. K., et al. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05285-4 · Cited by 3
Genetic Variants of Adrenoceptors
Ahles, A., & Engelhardt, S. H. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_676 · Cited by 3
Wang, Z., Zhang, J., Jiao, F., Wu, Y., Han, L., & Jiang, G. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.07.004 · Cited by 3
Wang, Y., & Li, S. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2420841 · Cited by 3
Fatty acids and colorectal cancer: Insights from Mendelian randomization
Jiang, D., Yang, W., & Zhang, Y. (2025) · Medicine · doi:10.1097/md.0000000000041768 · Cited by 3
“…the relationship between circulating PUFAs and CRC, they included relatively small sample sizes [19,20] and fewer SNPs. [11,12] In contrast, our study utilized serum fatty acids from over 110,000 participants in the UK Biobank, [14] enabling us to identify a greater number of eligible IVs.”
Lu, D., Yang, Y., & Yu, T. (2025) · Women & Health · doi:10.1080/03630242.2025.2539819 · Cited by 3
“For our study, GWAS summary statistics were sourced from credible consortia, focused mainly on European descendants (Barton et al. 2021; Nielsen et al. 2018; Richardson et al. 2022; Sakaue et al. 2021; van der Harst and Verweij 2018; Willer et al. 2013; Xue et al. 2018; Yengo et al. 2018).”
Shuai, C., Cheung, S., Zhang, L., Cao, H., Yuan, Y., Ge, Q., Wang, Y., Li, X., Zheng, J., & Xue, F. (2025) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s536186 · Cited by 3
Šeda, O., Junková, K., Malínská, H., Kábelová, A., Hüttl, M., Krupková, M., Marková, I., Liška, F., & Šedová, L. (2022) · Nutrients · doi:10.3390/nu14163428 · Cited by 3
“SHR20, has been recently associated to several obesity-related indices [41], type 2 diabetes [44], fasting insulin [45], and HDL cholesterol [46].”
BackgroundWeakened tanning ability is an important mechanism for evolutionary skin lightening in East Asians
Pu, Y., Pu, S., Chen, Y., Kong, Q., Liu, X., Zhao, Q., Xu, K., Li, M., Li, M., Xu, X., et al. (2024) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2024.03.001 · Cited by 3
Lin, B., Paterson, A. D., & Sun, L. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011221 · Cited by 3
Xiao, X., Xue, P., Yan, X., Li, Y., Shi, Y., Qin, H., Qin, D., Cao, W., Zou, Z., Wang, L., et al. (2024) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s474422 · Cited by 3
Wang, H., Tian, F., Yang, C., Cui, X., Ding, Y., Zhao, M., Wang, X., & Ge, S. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01519-1 · Cited by 3
Lu, J., Li, G. H., Hu, J., & Wang, Z. (2025) · Communications Biology · doi:10.1038/s42003-025-07860-z · Cited by 4
“4 cis -eQTLs located within or near (±100 kb) the ACLY gene region were retained 54 after excluding variants with cis -eQTLs with minor allele frequency (MAF) < 1% and F -statistics <10, ensuring minimal weak instrument bias 55 (Supplementary Data 12).”
Association of Plasma Omega-3 Fatty Acids With POAG
Kai, J.-Y., Dong, X., Li, D., Hu, D., Lança, C., Grzybowski, A. E., Ke, C., & Pan, C. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.12.3 · Cited by 4
“17 For POAG, we used GWAS summary data from a large-scale genome-wide meta-analysis combining the results from multiple original GWAS, which enabled the identification of novel causal variants for POAG risk loci.”
TEX10: A Novel Drug Target and Potential Therapeutic Direction for Sleep Apnea Syndrome
Fan, Z., Su, H., Qiao, T., Shi, S., Shi, P., & Zhang, A. (2025) · Nature and Science of Sleep · doi:10.2147/nss.s499895 · Cited by 3
The effects of fatty acids on psoriasis: A two‐sample mendelian randomization study
Huang, Y., Chen, Z., Wu, X., Chen, C., & Cai, L. (2024) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.16313 · Cited by 2
The association between fatty acids and atherosclerotic diseases: A mendelian randomization study
Wang, Y., Wang, C., & Wang, C. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.06.018 · Cited by 2
Li, B., Xu, J., Zheng, Q., Gao, J., Ren, Q., & Zhou, Y. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae843 · Cited by 2
Hipertrigliceridemia (> 150 mg/dl) como marcador de riesgo cardiovascular
López-Miranda, J. (2025) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2025.500822 · Cited by 4
Yi, J., Li, Q., Gong, R., Qin, J., & Hu, X. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.06.017 · Cited by 3
Whole genome sequence analysis of low-density lipoprotein cholesterol across 246 K individuals
Selvaraj, M. S., Li, X., Li, Z., Buren, E. V., Haidermota, S., Postupaka, D., Hornsby, W., Bis, J. C., Brody, J. A., Cade, B. E., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03698-0 · Cited by 5
“This variant was previously reported in the GWAS Catalog as a locus for cholesterol levels in small HDL, total lipids ratio in small LDL [14], and triglyceride levels [8].”
Zhang, J., Ran, S., Chen, L., Cai, M., Tian, F., Ai, B., Qian, S. E., Tabet, M., Howard, S. W., Yang, Y., et al. (2025) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.124.004986 · Cited by 2
D’Erasmo, L., Tramontano, D., & Arca, M. (2025) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000941 · Cited by 3
Zhou, X., Lu, J., Wang, Z., Cheng, K. K., & Li, G. H. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70565 · Cited by 3
Wulff, A. B., Varbo, A., Nordestgaard, A. G., & Nordestgaard, B. G. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2639678 · Cited by 2
“The association between genetically high concentrations of remnant cholesterol and increased risk of ASCVD have later been confirmed in the UK Biobank and several other large population cohorts [63–72] (Table 3).”
Gill, D., Woolf, B. A. R., Zagkos, L., Cronjé, H. T., & Tzoulaki, I. (2023) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.123.004204 · Cited by 2
Xu, C., Wu, W., Fan, Y., & Zhu, S. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1401880 · Cited by 2
Zhang, Z., Mo, Y., Li, Y., Pan, Y., Wang, S., Xu, M., Zhou, H., & Liu, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1359015 · Cited by 2
Shared genetic correlations between kidney diseases and sepsis
Zhang, T., Cui, Y., Jiang, S., Jiang, L., Song, L., Huang, L., Li, Y., Yao, J., & Li, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1396041 · Cited by 2
“…associations between the following traits: BUN (N=480,698), UACR (N=547,361), UA (N=110,347), eGFR (N=480,698), creatinine (N=110,051), kidney neoplasm (N=456,348), kidney stone disease (N=456,348), IgA nephropathy (N=477,784), diabetic nephropathy (N=452,280), and sepsis (N=344,644) (11 – 15).”
Liu, A., Liu, X., Wei, Y., Xiang, X., Chen, Y., Zheng, Z., Xu, C., Yang, S., & Zhao, K. (2024) · Cardiovascular Toxicology · doi:10.1007/s12012-024-09930-w · Cited by 2
Tang, X., Zhuang, H., & Yu, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-81591-9 · Cited by 2
“This GWAS used Nightingale Health’s high-throughput NMR spectroscopy to analyze and quantify 249 metabolites, comprising 3-OHB, AcAc, and acetone, involving non-fasting EDTA plasma samples obtained from randomly selected 121,584 UK Biobank participants 32 .”
Liu, S., Fu, Z., Liu, H., Wang, Y., Zhou, M., Ding, Z., & Feng, Z. (2024) · Biomedicines · doi:10.3390/biomedicines13010013 · Cited by 3
“Datasets related to lipid profiles [29–31], including levels of HDL, LDL, TC, TG, APOA1, APOB, and RC, were selected as the exposure data.”
InfluentialLyu, H., Fan, N., Wen, H., Zhang, X., Mao, H., Bian, Q., & Chen, J. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00896-2 · Cited by 2
Hu, Y., Cui, X., Lu, M., Guan, X., Li, Y., Zhang, L., Lin, L., Zhang, M., Zhang, M., Hao, J., et al. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.10.018 · Cited by 3
Zuo, B., Yu, B., Wang, P., Zhang, C., Zhao, C., Sun, Y., & Ai, S. (2025) · Nature and Science of Sleep · doi:10.2147/nss.s471466 · Cited by 2
Fan, H., Song, H., Fu, Q., Du, G., Bai, Y., Zhang, C., & Shi, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-02507-9 · Cited by 2
Dong, X., Aveyard, P. N., Guess, N. D., Huang, N., Huang, T., & Gao, M. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119594 · Cited by 2
Relationship Between Gut Microbiota and Phenylalanine Levels: A Mendelian Randomization Study
Liu, Z., Ye, M., Jin, H., Chen, W., Jieens, H., & Han, R. (2025) · MicrobiologyOpen · doi:10.1002/mbo3.70148 · Cited by 2
Lipoprotein profile and metabolic fine-mapping of genetic lipid risk lociPreprint
Suhre, K., AL-Ishaq, R. K., Belkadi, A., Habib, T., Halama, A., Stephan, N., Thareja, G., Zaghlool, S. B., Fauman, E. B., & Najafi-Shoushtari, S. H. (2022) · medRxiv · doi:10.1101/2022.06.12.22276286 · Cited by 3
Genealogy-based trait association with LOCATER boosts power at loci with allelic heterogeneity
Wang, X., Christ, R., Young, E. P., Kang, C. J., Das, I., Belter, E. A., Laakso, M., Aslett, L. J. M., Steinsaltz, D., Stitziel, N. O., et al. (2026) · Genome Research · doi:10.1101/gr.280372.124 · Cited by 2
Genetic Architecture of Circulating Metabolic Biomarkers Across Ancestral PopulationsPreprint
Takeuchi, Y., Koido, M., He, Y., Nakamura, S., Liu, X., Itokawa, N., Tsuru, H., Sagiya, Y., Nagai, A., Morisaki, T., et al. (2025) · medRxiv · doi:10.64898/2025.12.03.25341540 · Cited by 2
Cholerton, B., Godrich, D., Pasteris, J., Rivero, J., Martin, E. R., Kunkle, B. W., Naj, A. C., Hamilton-Nelson, K. L., Wang, H., Lee, W.-P., et al. (2026) · PLOS Genetics · doi:10.1371/journal.pgen.1012170 · Cited by 1
Targeted Metabolomics Analysis of Individuals Carrying the ANGPTL8 R59W Variant
Abu‐Farha, M., Joseph, S., Mohammad, A., Channanath, A. M., Taher, I., Al‐Mulla, F., Mujammami, M. H., Thanaraj, T. A., Abubaker, J. A., & Rahman, A. M. A. (2023) · Metabolites · doi:10.3390/metabo13090972 · Cited by 2
Sequence Variant Analysis of the APOCII Locus among an Arab Cohort
Al‐Bustan, S. A., Alrashid, M. H., Al‐Serri, A., Annice, B. G., & Bahbahani, H. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216293 · Cited by 2
A Genome-Wide Association Study of Serum Metabolite Profiles in Septic Shock Patients
Daubney, E. R., D’Urso, S., Cuéllar-Partida, G., Rajbhandari, D., Peach, E., de Guzman, E., McArthur, C. J., Rhodes, A., Meyer, J., Finfer, S. R., et al. (2024) · Critical Care Explorations · doi:10.1097/cce.0000000000001030 · Cited by 1
Jiang, S., & Wang, S. (2024) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346241283260 · Cited by 1
Ma, X., Zhu, P.-P., Yang, Q., Sun, Y., Ou, C., & Li, L. (2024) · Healthcare · doi:10.3390/healthcare12181882 · Cited by 1
“For glycoprotein acetyls (GlycA), we extracted the data from a GWAS study conducted among 115,082 UK Biobank participants of European ancestry [30].”
MethodHuang, H., Qin, J., Zhi, W., Wang, C., Chen, C., Liu, Y., Li, H., Cao, S., & Yang, X. (2024) · Translational Cancer Research · doi:10.21037/tcr-24-1142 · Cited by 1
Genetic determinants of angiotensin-converting enzyme levels (data from genome-wide studies)
Камышникова, Л. А., Efremova, O. A., Владимирович, Ф. В., Болховитина, О. А., & Churnosov, M. I. (2024) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2024-2446 · Cited by 1
Gao, X., Zhang, W., & Wang, F. (2025) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2025.112101 · Cited by 2
Wang, L., Ding, Y., Tang, Y., Yang, M., Yang, Z., Yang, X., & Xia, J. (2025) · BMC Neurology · doi:10.1186/s12883-025-04207-3 · Cited by 2
“During the analysis, sex, age, fasting status and genotyping batch were revised [24].”
Luan, H., Wang, T., Wang, R., Wang, Y., Liu, Y., Sheng, W., Guo, J., Ji, H., Liu, X., Xue, X., et al. (2025) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2025.2513601 · Cited by 1
“In parallel, 249 bits of data were obtained from a study performed in 2022, with sample sizes varying from 11,051 to 115,082 for different metabolites [22].”
Hypertriglyceridemia (> 150 mg/dL) as a marker of cardiovascular risk
López-Miranda, J. (2025) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2025.500822 · Cited by 2
Zheng, D., & Chen, Z. (2025) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2025.109037 · Cited by 1
Li, Q., Zhao, C., Lei, D., Tong, W., & Yue, C. (2025) · Journal of Dairy Science · doi:10.3168/jds.2025-26254 · Cited by 1
Liang, P., Li, C., Li, Y., Xiong, J., Mi, J., & Xiao, P. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70540 · Cited by 2
“The GWASs were conducted by Richardson et al. with adjustments for sex, age, genotyping chip, and fasting duration [27].”
Lu, Y., Xu, H., Sun, Y., Ihejirika, S. A., Chiang, C. W. K., Darst, B. F., Song, S., Shen, Y., & Ye, K. (2025) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2025.107524 · Cited by 2
Fu, J., Zhang, Z., Xu, Y., Han, L., Fan, H., & Lu, Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120057 · Cited by 1
Yu, J., Yang, C., Yang, J., Lai, X., & Fang, J. (2025) · Medicine · doi:10.1097/md.0000000000044920 · Cited by 1
“Specific information on DHA levels was obtained from an in-depth GWAS conducted by Richardson in 2022, [16] which included data from individuals of European descent.”
Yang, Y., Wang, X., & Yang, W. (2025) · Journal of Dairy Science · doi:10.3168/jds.2025-26097 · Cited by 1
Fan, F., Chen, Y., Peng, W., Yan, W., Tan, H., Zhang, C., Tan, S., Xiao, Q., Gao, Y. H., Zhang, J., et al. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70967 · Cited by 1
Lin, X., Wang, J., Zhang, W., Jiang, C., Jin, Y., Cheng, K. K., Lam, T. H., & Xu, L. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.12.021 · Cited by 1
Metadata
- Authors
- Richardson, T. G., Leyden, G. M., Wang, Q., Bell, J. A., Elsworth, B., Davey Smith, G., & Holmes, M. V.
- Affiliations
- University of Bristol (GB)
- University of Oxford (GB)
- Corresponding author
- Richardson, Tom G.
- ORCID
- Venue
- PLOS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-02-25
- Volume
- 20
- Issue
- 2
- Pages
- e3001547
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC8906647
- OpenAlex
- W4214506665
- Cited by
- 304
- References
- 51
- Citations by year
- 2026: 52 · 2025: 103 · 2024: 95 · 2023: 41 · 2022: 12
- FWCI
- 60.45
- Type
- journal article
- Language
- en
- Update notices
- new_version (2022-03-09)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Biology (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion, cc-by-nc)
- Explore Bristol Research (publishedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- British Heart Foundation (FS/18/23/33512)
- Medical Research Council (MC_UU_00011/1)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- lipid therapy, Mendelian randomization, blood metabolome, coronary artery disease risk, LDL cholesterol lowering, triglyceride lowering, HMGCR, PCSK9, NPC1L1, cholesteryl ester transfer protein, apolipoprotein C-III, ANGPTL3, ANGPTL4, lipoprotein lipase, glycoprotein acetyls, inflammatory markers, metabolic phenotypes, treatment response biomarkers
- MeSH terms
- Proprotein Convertase 9, Angiopoietin-like Proteins, Angiopoietin-Like Protein 3, Cholesterol, Humans, Lipoproteins, Cholesterol, HDL, Cholesterol, LDL, Triglycerides, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.